Emergent BioSolutions Inc. — Director's Dealing 2024

Nov 12, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2024-10-29

Reporting Person: Perl Jessica (SVP, General Counsel, Corp Sec)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6805	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to buy)	$12.95	2030-02-09	Common Stock (15445)		Direct
Employee Stock Option (Right to buy)	$2.33	2031-03-12	Common Stock (18000)		Direct

Footnotes

F1: Granted on February 10, 2023 and vesting in three equal installments beginning on the day prior to the anniversary date of the grant.

F2: Granted on March 13, 2024 and vesting in three equal installments beginning on the day prior to the anniversary date of the grant.